Relapsed or Refractory Myeloma: Your Guide
12 Articles
Featured Channels
FDA Approves Time-Saving Under-the-Skin Sarclisa for Multiple Myeloma
Written by Ted SamsonGVHD After a Donor Stem Cell Transplant for Myeloma: Symptoms, Risk, and More
Medically reviewed by Leonora Valdez-Rojas, M.D.FDA-Approved Drug Combo Lowers Myeloma Progression Risk by 83%
Written by Ted SamsonBecome a member to get even more